Integra LifeSciences Holdings Corp (IART) - Financial and Strategic SWOT Analysis Review
April 2019
65
About the Report
About the Report
Integra LifeSciences Holdings Corp (IART)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description-A detailed description of the company's operations and business divisions.
- Corporate strategy-Analyst's summarization of the company's business strategy.
- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.
- Company history-Progression of key events associated with the company.
- Major products and services-A list of major products, services and brands of the company.
- Key competitors-A list of key competitors to the company.
- Key employees-A list of the key executives of the company.
- Executive biographies-A brief summary of the executives' employment history.
- Key operational heads-A list of personnel heading key departments/functions.
- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities-A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Integra LifeSciences Holdings Corp (Integra) is a medical technology company, which offers engineered collagen-based product lines. The company's portfolio consists of surgical instruments, advanced wound care and orthopedic hardware, specialty metal implants, dermal regeneration products, orthobiologic products, tissue-engineered wound dressings, and nerve and tendon repair products. Its neurosurgery products include ultrasonic surgery systems, systems for measurement of various brain parameters, cranial stabilization and brain retraction systems, and others. Integra's products find application in orthopedic extremity surgery, neurosurgery, and reconstructive and general surgery. Integra serves hospitals, outpatient surgery centers, physician, veterinarian and dental practices. The company markets its solutions through direct sales representatives and an extensive network of distributors. Integra is headquartered in Plainsboro, New Jersey, the US.
Integra LifeSciences Holdings Corp Key Recent Developments
Mar 14,2019 Integra LifeSciences Announces the Approval of DuraGen in Japan | Integra LifeSciences Holdings Corporation
Feb 21,2019 Integra LifeSciences reports fourth quarter and full-year 2018 financial results and provides 2019 financial guidance
Jan 09,2019 Integra LifeSciences appoints Rhonda Germany Ballintyn as Director
Jan 09,2019 Integra LifeSciences Appoints Rhonda Germany Ballintyn as Director | Integra LifeSciences Holdings Corporation
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Products
Companies
Zimmer Biomet Holdings Inc
Wright Medical Group NV
Stryker Corp
Smith & Nephew Plc
MiMedx Group Inc
Medtronic Plc
LifeCell Corp
Johnson & Johnson
DePuy Synthes Inc
Becton Dickinson and Co
Table of Contents
Table of Contents
Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1-About the Company
Integra LifeSciences Holdings Corp-Key Facts
Integra LifeSciences Holdings Corp-Key Employees
Integra LifeSciences Holdings Corp-Key Employee Biographies
Integra LifeSciences Holdings Corp-Major Products and Services
Integra LifeSciences Holdings Corp-History
Integra LifeSciences Holdings Corp-Company Statement
Integra LifeSciences Holdings Corp-Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2-Company Analysis
Company Overview
Integra LifeSciences Holdings Corp-Business Description
Business Segment: Codman Specialty Surgical
Overview
Performance
Business Segment: Orthopedics and Tissue Technologies
Overview
Performance
Geographical Segment: Asia Pacific
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Rest of World
Performance
Geographical Segment: The US
Performance
R&D Overview
Integra LifeSciences Holdings Corp-Corporate Strategy
Integra LifeSciences Holdings Corp-SWOT Analysis
SWOT Analysis-Overview
Integra LifeSciences Holdings Corp-Strengths
Integra LifeSciences Holdings Corp-Weaknesses
Integra LifeSciences Holdings Corp-Opportunities
Integra LifeSciences Holdings Corp-Threats
Integra LifeSciences Holdings Corp-Key Competitors
Section 3-Company Financial Ratios
Financial Ratios-Capital Market Ratios
Financial Ratios-Annual Ratios
Performance Chart
Financial Performance
Financial Ratios-Interim Ratios
Financial Ratios-Ratio Charts
Section 4-Company's Lifesciences Financial Deals and Alliances
Integra LifeSciences Holdings Corp, Medical Equipment, Deals By Year, 2013 to YTD 2019
Integra LifeSciences Holdings Corp, Medical Equipment, Deals By Type, 2013 to YTD 2019
Integra LifeSciences Holdings Corp, Recent Deals Summary
Section 5-Company's Recent Developments
Mar 14, 2019: Integra LifeSciences Announces the Approval of DuraGen in Japan | Integra LifeSciences Holdings Corporation
Feb 21, 2019: Integra LifeSciences reports fourth quarter and full-year 2018 financial results and provides 2019 financial guidance
Jan 09, 2019: Integra LifeSciences appoints Rhonda Germany Ballintyn as Director
Jan 09, 2019: Integra LifeSciences Appoints Rhonda Germany Ballintyn as Director | Integra LifeSciences Holdings Corporation
Jan 08, 2019: Integra LifeSciences announces preliminary fourth quarter 2018 financial results
Nov 20, 2018: Integra XT Revision Total Ankle Replacement System Offers Innovative Solution to Ankle Arthroplasty Revision Surgery
Oct 31, 2018: Integra LifeSciences reports third quarter 2018 financial results
Sep 05, 2018: 2018 Veeva R&D summit to showcase advances for speeding product development
Jul 25, 2018: Integra LifeSciences Reports Second Quarter 2018 Financial Results
May 07, 2018: Integra LifeSciences Announces Amendment and Extension of Credit Facility
Section 6-Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Figure
List of Figures
Integra LifeSciences Holdings Corp, Performance Chart (2014-2018)
Integra LifeSciences Holdings Corp, Ratio Charts
Integra LifeSciences Holdings Corp, Medical Equipment, Deals By Year, 2013 to YTD 2019
Integra LifeSciences Holdings Corp, Medical Equipment, Deals by Type, 2013 to YTD 2019
List of Table
List of Tables
Integra LifeSciences Holdings Corp, Key Facts
Integra LifeSciences Holdings Corp, Key Employees
Integra LifeSciences Holdings Corp, Key Employee Biographies
Integra LifeSciences Holdings Corp, Major Products and Services
Integra LifeSciences Holdings Corp, History
Integra LifeSciences Holdings Corp, Other Locations
Integra LifeSciences Holdings Corp, Subsidiaries
Integra LifeSciences Holdings Corp, Key Competitors
Integra LifeSciences Holdings Corp, Ratios based on current share price
Integra LifeSciences Holdings Corp, Annual Ratios
Integra LifeSciences Holdings Corp, Annual Ratios (Cont...1)
Integra LifeSciences Holdings Corp, Annual Ratios (Cont...2)
Integra LifeSciences Holdings Corp, Interim Ratios
Integra LifeSciences Holdings Corp, Medical Equipment, Deals By Year, 2013 to YTD 2019
Integra LifeSciences Holdings Corp, Medical Equipment, Deals By Type, 2013 to YTD 2019
Integra LifeSciences Holdings Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.